Adipogenesis-related increase of semicarbazide-sensitive amine oxidase and monoamine oxidase in human adipocytes. 2007

Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
U858 INSERM, I2MR, IFR 31, CHU Rangueil, BP 84225, 31432 Toulouse Cedex 4, France.

A strong induction of semicarbazide-sensitive amine oxidase (SSAO) has previously been reported during murine preadipocyte lineage differentiation but it remains unknown whether this emergence also occurs during adipogenesis in man. Our aim was to compare SSAO and monoamine oxidase (MAO) expression during in vitro differentiation of human preadipocytes and in adipose and stroma-vascular fractions of human fat depots. A human preadipocyte cell strain from a patient with Simpson-Golabi-Behmel syndrome was first used to follow amine oxidase expression during in vitro differentiation. Then, human preadipocytes isolated from subcutaneous adipose tissues were cultured under conditions promoting ex vivo adipose differentiation and tested for MAO and SSAO expression. Lastly, human adipose tissue was separated into mature adipocyte and stroma-vascular fractions for analyses of MAO and SSAO at mRNA, protein and activity levels. Both SSAO and MAO were increased from undifferentiated preadipocytes to lipid-laden cells in all the models: 3T3-F442A and 3T3-L1 murine lineages, human SGBS cell strain or human preadipocytes in primary culture. In human subcutaneous adipose tissue, the adipocyte-enriched fraction exhibited seven-fold higher amine oxidase activity and contained three- to seven-fold higher levels of mRNAs encoded by MAO-A, MAO-B, AOC3 and AOC2 genes than the stroma-vascular fraction. MAO-A and AOC3 genes accounted for the majority of their respective MAO and SSAO activities in human adipose tissue. Most of the SSAO and MAO found in adipose tissue originated from mature adipocytes. Although the mechanism and role of adipogenesis-related increase in amine oxidase expression remain to be established, the resulting elevated levels of amine oxidase activities found in human adipocytes may be of potential interest for therapeutic intervention in obesity.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D005260 Female Females
D006631 Amine Oxidase (Copper-Containing) A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. Diamine Oxidase,Histaminase,Amine Oxidase, Copper-Containing,Copper Amine Oxidase,Diaminobenzidine Oxidase,Semicarbazide-Sensitive Amine Oxidase,Xylylene Diamine Oxidase,Amine Oxidase, Copper,Amine Oxidase, Copper Containing,Amine Oxidase, Semicarbazide-Sensitive,Copper-Containing Amine Oxidase,Diamine Oxidase, Xylylene,Oxidase, Copper Amine,Oxidase, Copper-Containing Amine,Oxidase, Diamine,Oxidase, Diaminobenzidine,Oxidase, Semicarbazide-Sensitive Amine,Oxidase, Xylylene Diamine,Semicarbazide Sensitive Amine Oxidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
October 1984, Naunyn-Schmiedeberg's archives of pharmacology,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
January 1990, Journal of neural transmission. Supplementum,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
August 2015, Molecular and cellular endocrinology,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
May 1985, The Journal of pharmacy and pharmacology,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
January 1988, Comparative biochemistry and physiology. C, Comparative pharmacology and toxicology,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
October 2009, Medical science monitor : international medical journal of experimental and clinical research,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
January 2003, Inflammopharmacology,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
May 2001, The Journal of pharmacology and experimental therapeutics,
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
March 2002, Journal of neural transmission (Vienna, Austria : 1996),
Sandy Bour, and Danièle Daviaud, and Sandra Gres, and Corinne Lefort, and Danielle Prévot, and Antonio Zorzano, and Martin Wabitsch, and Jean-Sébastien Saulnier-Blache, and Philippe Valet, and Christian Carpéné
January 2003, Inflammopharmacology,
Copied contents to your clipboard!